Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbbas, Amar-
dc.contributor.authorVella Szijj, Janis-
dc.contributor.authorAzzopardi, Lilian M.-
dc.contributor.authorSerracino-Inglott, Anthony-
dc.identifier.citationAbbas, A., Vella Szijj, J., Azzopardi, L.M., & Serracino-Inglott, A. (2019). Orphan drug policies in different countries. Journal of Pharmaceutical Health Services Research, 1-8en_GB
dc.description.abstractObjectives: Due to the low prevalence of rare diseases (RDs) and the small number of individuals affected with a RD, challenges complicate the development of and accessibility to medications and medical devices to prevent, identify, treat or cure these RDs. The aims of this study were to analyse and compare regulations and policies related to accessibility of orphan drugs (ODs) in different countries which have policies or systems in place which are specific for RDs and ODs in Europe and the United States (US). Methods: A comprehensive literature review was carried out. A total of 20 120 articles which contained information about accessibility and legislations, regulations and governmental policies related to RDs and ODs were retrieved. Key findings: Sixty-eight articles were included in this study. Classification of information related to 24 countries was based on six themes: OD policies, marketing authorisations, incentives offered, pricing of ODs, reimbursement and pharmacovigilance. The EU and United States have adopted policies and regulations aimed to improve OD accessibility in the last 20 years. Although all included countries had an OD legislation, only 16 countries had an OD or RD plan in place. Conclusions: Comparison of different legislations and policies in each country can be used to identify and address deficiencies in the field of RDs and improve accessibility of ODs.en_GB
dc.publisherRoyal Pharmaceutical Societyen_GB
dc.subjectOrphan drugsen_GB
dc.subjectRare diseases -- Treatmenten_GB
dc.titleOrphan drug policies in different countriesen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holderen_GB
dc.publication.titleJournal of Pharmaceutical Health Services Researchen_GB
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
  Restricted Access
435.24 kBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.